Position
Fidelity in Olema Pharmaceuticals, Inc.
Back to the book · All holders of OLMA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$24.9M$14.91 → $12.51
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 5.02M | $125.6M | — | — | — | 0.0% |
| Q1 2026 | 10.4M | $154.9M | $14.91 | −$50.7M | $80M | 0.0% |
| Q2 2026 | 12.1M | $151.9M | $12.51 | −$24.9M | $22M | 0.0% |